Abstract
A third of developed countries do not test for maternal group B streptococcus colonisation in pregnant women and follow a strategy of identifying maternal risk factors for EOGBS disease in the baby, and offering those 'higher risk groups' intrapartum antimicrobial prophylaxis. Hasperhoven et al (BJOG, 2020) present an updated systematic review of culture-based testing for group B streptococcus (GBS) colonisation in women or risk factor-based approach for prevention of newborn early-onset GBS (EOGBS) disease. The review identified 17 observational studies, of which 15 provided data for a meta-analysis and 11 directly compared screening protocols with risk-based strategies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: BJOG : an international journal of obstetrics and gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
